Andere Sprachen MedRx Co., Ltd

Aktien

A1J7MB

JP3921220004

4586

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 02.05.2024			% 5 Tage	% 1. Jan.
113 ^JPY	-2,59 %		-2,59 %	-25,17 %

2023	MedRx Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2023	CI
2019	MedRx Co. Ltd. meldet konsolidierte Ergebniszahlen für die neun Monate bis zum 30. September 2019; gibt konsolidierte Ergebnisprognose für das am 31. Dezember 2019 endende Jahr ab	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

MedRx : Notice of revised forecasts of consolidated financial results	24.04.
MEDRx : Collaboration Partner, Alto Neuroscience, Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia	24.04.
MedRx Co., Ltd announced that it has received ¥1.9076 million in funding from Evolution Capital Management LLC	05.02.
MedRx Co., Ltd announced that it expects to receive ¥1.9076 million in funding from Evolution Capital Management LLC	11.01.
MedRx : Fair Research Inc. Report ( October 12, 2023)	26.10.23
MedRx : Prospect of NDA Re-Submission for MRX-5LBT	10.10.23
MedRx : and Alto Neuroscience Enter Development Agreement for Novel CNS Targeted Medication	25.09.23
MedRx : H1 FY2023 Business Highlight & Financial Results	28.08.23
MedRx : Summary of Business Results for the Second Quarter Ended June 30, 2023 (Consolidated)	18.08.23
MedRx Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	12.05.23
MedRx : Fair Research Inc. Report ( April 10, 2023)	20.04.23
MedRx Co., Ltd announced that it has received ¥1.2272 million in funding from Evolution Capital Management, LLC	24.03.23
MedRx Co., Ltd announced that it expects to receive ¥1.2272 million in funding from Evolution Capital Management, LLC	08.03.23
MedRx : FY2022Business Highlight & Financial Results	02.03.23
MedRx : Fair Research Inc. Report (September 14, 2022)	28.09.22
MedRx : H1 FY2022 Business Highlight & Financial Results	30.08.22
MedRx Co., Ltd announced that it expects to receive ¥3.904 million in funding	22.08.22
MedRx Co., Ltd announced that it has received ¥552.489 million in funding from Macquarie Bank Limited, Investment Arm	03.06.21
MedRx Co., Ltd announced that it expects to receive funding from Macquarie Bank Limited, Investment Arm	18.05.21
Evolution Capital Withdraws Shareholder Proposal to MedRx	31.12.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen MedRx Co., Ltd

Aktien

A1J7MB

JP3921220004

4586

Andere Sprachen

Filter